The rate-setting Federal Open Market Committee downgraded its collective outlook for economic growth to 1.7%, down from the last projection of 2.1% in December.Read More

You might also be interested in reading Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025.